BioHealth News

Issue Brief: March-In Rights Under the Bayh-Dole Act (February 2023)

Issue Brief: March-In Rights Under the Bayh-Dole Act (February 2023)

The biggest controversy surrounding the Bayh-Dole Act — which allows academic institutions and private contractors to own and manage inventions they make with federal funds…

Read More
ApogeeBio Postdoctoral Programme

ApogeeBio Postdoctoral Programme

Dear scientific community, The European programme ApogeeBio has launched the 2nd international call for 12 postdoctoral positions in Genopole biocluster, Paris region (FR). It…

Read More
Baltimore’s KaloCyte Partners on $46M DARPA Program to Develop Synthetic Blood Product · BioBuzz

Baltimore’s KaloCyte Partners on $46M DARPA Program to Develop Synthetic Blood Product · BioBuzz

KaloCyte’s experimental synthetic red blood cell product ErythroMer could provide a solution to the high need for treating trauma in both military and civilian…

Read More
Phlow Corp. Announces Formation of Business Advisory Board, New Board of Directors Appointment and Corporate President as Company Accelerates Towards Next Stage of Growth

Phlow Corp. Announces Formation of Business Advisory Board, New Board of Directors Appointment and Corporate President as Company Accelerates Towards Next Stage of Growth

Richmond, Virginia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Phlow Corp., a U.S.-based public benefit corporation leveraging advanced manufacturing processes to re-imagine the domestic production…

Read More
Canon posts record revenues in medical business unit

Canon posts record revenues in medical business unit

Stronger sales in Europe and the U.S. helped offset declining demand in Japan for the Medical Business Unit of Japanese industrial conglomerate Canon for…

Read More
Cartesian Therapeutics Announces Dosing of First Participant in a Phase 2b Randomized Clinical Trial for Generalized Myasthenia Gravis – Cartesian

Cartesian Therapeutics Announces Dosing of First Participant in a Phase 2b Randomized Clinical Trial for Generalized Myasthenia Gravis – Cartesian

⦁ First placebo-controlled study of an engineered cell therapy Gaithersburg, MD, January 31, 2023 – Cartesian Therapeutics, a fully integrated, clinical-stage biotechnology company pioneering…

Read More
AURP BIO Health Caucus 2023

AURP BIO Health Caucus 2023

AURP’s BioHealth Caucus will examine topics, including: Economic impact of the biotech industry in the U.S. New biotech hubs growing in VA, NC, OK,…

Read More
Montgomery County Perfect Home for ARPA-H

Montgomery County Perfect Home for ARPA-H

The newly established Advanced Research Projects Agency for Health (ARPA-H) will accelerate cutting-edge biomedical and health research, moving discoveries from the laboratory to patients…

Read More
TEDCO chooses 24 MD companies for SBIR/STTR Proposal Lab cohort

TEDCO chooses 24 MD companies for SBIR/STTR Proposal Lab cohort

TEDCO, Maryland’s economic engine for technology companies, Tuesday announced the selection of 24 Maryland companies to participate in the FY2023 FAST SBIR/STTR Proposal Lab cohort. This program, now…

Read More
WJLA: Maryland’s Medcura Recognized For Innovative Biosurgical Tech (Video)

WJLA: Maryland’s Medcura Recognized For Innovative Biosurgical Tech (Video)

Prince George's County, Maryland based Medcura’s is pioneering a proprietary biosurgical technology that has repeatedly demonstrated the rapid arrest of difficult-to-control surgical bleeding. With…

Read More
Quality Biological Inks 24,000 SF Lease at Shady Grove Development Park in Gaithersburg, MD

Quality Biological Inks 24,000 SF Lease at Shady Grove Development Park in Gaithersburg, MD

GAITHERSBURG, M.D. – Transwestern Real Estate Services (TRS) announces Quality Biological, Inc. has signed a 24,000-square-foot lease at Shady Grove Development Park, a 745,000-square-foot, 10-building mixed-use project…

Read More
Tonix Pharmaceuticals Announces Research Agreement with University of Maryland, Baltimore for Study

Tonix Pharmaceuticals Announces Research Agreement with University of Maryland, Baltimore for Study

Tonix Pharmaceuticals Announces Research Agreement with University of Maryland, Baltimore, to Study TNX-1500 (Fc-modified anti-CD40L mAb) for the Prevention of Rejection in Heart Xenograft…

Read More
AMPEL BioSolutions’ Breakthrough Predicts Drug Options for Fibromyalgia

AMPEL BioSolutions’ Breakthrough Predicts Drug Options for Fibromyalgia

CHARLOTTESVILLE, Va., Jan. 31, 2023 /PRNewswire/ -- AMPEL BioSolutions today announces a breakthrough in precision and personalized medicine that could revolutionize the way doctors treat chronic pain syndromes,…

Read More
Deka Biosciences Receives FDA Clearance of DK210 (EGFR) Investigational New Drug Application

Deka Biosciences Receives FDA Clearance of DK210 (EGFR) Investigational New Drug Application

GERMANTOWN, Md., Jan. 30, 2023 /PRNewswire/ -- Deka Biosciences ("Deka"), a biotech company focused on developing novel cytokine therapies to treat cancer and inflammatory…

Read More
WBJ: Germantown’s Precigen raises $75M to advance treatments for rare diseases

WBJ: Germantown’s Precigen raises $75M to advance treatments for rare diseases

Germantown’s Precigen Inc. (NASDAQ: PGEN) has raised $75 million in a public offering that closed Friday and intends to use the proceeds to speed…

Read More